cis-1-((tert-Butoxycarbonyl)amino)-3-methoxycyclobutane-1-carboxylic acid

Catalog No. :
ACXCZQ284
CAS No. :
2166823-89-6
Molecular Formula :
C11H19NO5
Molecular Weight :
245.27

IUPAC Name:(1s,3s)-1-((tert-butoxycarbonyl)amino)-3-methoxycyclobutane-1-carboxylic acid

cis-1-((tert-Butoxycarbonyl)amino)-3-methoxycyclobutane-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$314.00Login to see priceInquiryInquiry
100mg97%$460.00Login to see priceInquiryInquiry
250mg97%$652.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-1-((tert-Butoxycarbonyl)amino)-3-methoxycyclobutane-1-carboxylic acid
IUPAC Name(1s,3s)-1-((tert-butoxycarbonyl)amino)-3-methoxycyclobutane-1-carboxylic acid
Molecular FormulaC11H19NO5
Molecular Weight245.27
SMILESN(C(OC(C)(C)C)=O)[C@]1(C(O)=O)C[C@H](OC)C1
InChI KeyDUZSBLQOTMZVAN-DGFRNANFSA-N
Synonym(1s,3s)-1-{[(tert-butoxy)carbonyl]amino}-3-methoxycyclobutane-1-carboxylic acid;Cyclobutanecarboxylic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]-3-methoxy-, cis-
CAS No.2166823-89-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXCZQ284 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKBMW582 route compound structure diagram
    ACKBMW5822193051-80-6 In Stock
  4. Then
  5. ACXCZQ284 route product structure diagram
    ACXCZQ2842166823-89-6
Inquiry

2. ACXCZQ284 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXCZQ284 route product structure diagram
    ACXCZQ2842166823-89-6
Inquiry

Comments (0)